Brayan E. Gonzales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brayan E. Gonzales has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Theresa J. Ochoa
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
4 shared publications - David Durand
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
2 shared publications - Eduardo Chaparro
Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú. Departamento de Pediatría, Hospital Nacional Cayetano Heredia, Lima, Perú
2 shared publications - Erik H. Mercado
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
2 shared publications - Francisco Campos
Grupo Peruano de Investigación en Neumococo (GPIN), Lima, Perú. Departamento de Pediatría, Hospital Nacional Docente Madre-Niño San Bartolomé, Lima, Perú
2 shared publications - Isabel Reyes
Grupo Peruano de Investigación en Neumococo (GPIN), Lima, Perú. Servicio de Hospitalización, Hospital de Emergencias Pediátricas, Lima, Perú
2 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, 1-29
Inequalities in complete pneumococcal vaccination among Peruvian children before and after the COVID-19 pandemic: An evaluation using demographic and health surveys from 2018 to 2023
This study assessed changes in complete pneumococcal vaccination coverage (CPVC) among Peruvian children p = 0.003), then returned to pre Covid levels from 2021 onward (72.2% in 2023; p = 0.001), particularly in Lima Metropolitana. Puno (53.3–58.6%) and Madre de Dios (50.9–62.1%) consistently showed the lowest coverage. Nationally, wealth- or sociodemographic related inequalities were minimal; however, regional interactions indicated that the effect of wealth on CPVC varied by area. Depending on the region, factors such as age group, household members and mather’s education were associated with lower CPVC, whereas age at first pregnancy, institutional birth, antenatal care and access to information increased CPVC. Ucayali showed persistently higher CPVC among wealthier populations. Despite a temporary decline during the pandemic, CPVC in Peru rapidly recovered, although regional gaps persist.
- 27 March 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, 1-29
Open AccessInequalities in complete pneumococcal vaccination among Peruvian children before and after the COVID-19 pandemic: An evaluation using demographic and health surveys from 2018 to 2023
This study assessed changes in complete pneumococcal vaccination coverage (CPVC) among Peruvian children p = 0.003), then returned to pre Covid levels from 2021 onward (72.2% in 2023; p = 0.001), particularly in Lima Metropolitana. Puno (53.3–58.6%) and Madre de Dios (50.9–62.1%) consistently showed the lowest coverage. Nationally, wealth- or sociodemographic related inequalities were minimal; however, regional interactions indicated that the effect of wealth on CPVC varied by area. Depending on the region, factors such as age group, household members and mather’s education were associated with lower CPVC, whereas age at first pregnancy, institutional birth, antenatal care and access to information increased CPVC. Ucayali showed persistently higher CPVC among wealthier populations. Despite a temporary decline during the pandemic, CPVC in Peru rapidly recovered, although regional gaps persist.
- Open Access
- 3 February 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (2)
Genomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru
To determine changes in the pneumococcal serotypes, sequence types (STs), clonal complexes (CCs) and the frequency of antimicrobial resistance genes after the introduction of pneumococcal conjugate vaccines (PCVs) in Lima, Peru. Retrospective multicentre study analysing whole-genome sequencing (WGS) data from three passive surveillance studies of invasive pneumococcal disease (IPD) in paediatric patients in Lima (2006–2020). Pneumococcal typing and antimicrobial resistance were analysed using in silico genomic tools. CCs were identified with eBURST and phylogenetic results were visualized using PHYLOViZ. 262 pneumococcal isolates were analysed (104 from IPD1, 70 from IPD2 and 88 from IPD3), 55.3% from children under 2 years old, 53.1% from patients with pneumonia and 28.5% with meningitis. After the introduction of PCVs, vaccine serotypes decreased, while serotype 19A and non-vaccine serotypes increased. The predominant STs were ST156 in IPD1 ( n =25) and in IPD2 ( n =7); and ST320 ( n =38) and ST230 ( n =15) in IPD3. Sixteen CC were identified, the most frequent were CC1421 ( n =58) and CC156 ( n =36). The overall penicillin non-susceptibility (NS) increased from 21.8% in IPD1 to 28.6% in IPD3, ceftriaxone-NS increased from 10% to 13.1% and macrolide-NS from 24.8% to 85.7% respectively. Resistance markers for macrolides, tetracycline and cotrimoxazole increased post-PCV13. WGS predicted antimicrobial resistance with high concordance, though some discrepancies were noted with phenotypic testing methods. Important changes in the distribution of serotype and ST, especially among vaccine serotypes, have been observed. These findings highlight the importance of monitoring vaccine effectiveness and tracking changes in bacterial populations to guide future vaccine implementation.
- 3 February 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (2)
Open AccessGenomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru
To determine changes in the pneumococcal serotypes, sequence types (STs), clonal complexes (CCs) and the frequency of antimicrobial resistance genes after the introduction of pneumococcal conjugate vaccines (PCVs) in Lima, Peru. Retrospective multicentre study analysing whole-genome sequencing (WGS) data from three passive surveillance studies of invasive pneumococcal disease (IPD) in paediatric patients in Lima (2006–2020). Pneumococcal typing and antimicrobial resistance were analysed using in silico genomic tools. CCs were identified with eBURST and phylogenetic results were visualized using PHYLOViZ. 262 pneumococcal isolates were analysed (104 from IPD1, 70 from IPD2 and 88 from IPD3), 55.3% from children under 2 years old, 53.1% from patients with pneumonia and 28.5% with meningitis. After the introduction of PCVs, vaccine serotypes decreased, while serotype 19A and non-vaccine serotypes increased. The predominant STs were ST156 in IPD1 ( n =25) and in IPD2 ( n =7); and ST320 ( n =38) and ST230 ( n =15) in IPD3. Sixteen CC were identified, the most frequent were CC1421 ( n =58) and CC156 ( n =36). The overall penicillin non-susceptibility (NS) increased from 21.8% in IPD1 to 28.6% in IPD3, ceftriaxone-NS increased from 10% to 13.1% and macrolide-NS from 24.8% to 85.7% respectively. Resistance markers for macrolides, tetracycline and cotrimoxazole increased post-PCV13. WGS predicted antimicrobial resistance with high concordance, though some discrepancies were noted with phenotypic testing methods. Important changes in the distribution of serotype and ST, especially among vaccine serotypes, have been observed. These findings highlight the importance of monitoring vaccine effectiveness and tracking changes in bacterial populations to guide future vaccine implementation.
- Open Access
- 21 November 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (4) , 416-23
Distribución de serotipos, biotipo y sensibilidad antibiótica de Haemophilus influenzae en niños portadores nasofaríngeos en Lima, Perú
Luego de la introducción de la vacuna Hib (Haemophilus influenzae tipo b) disminuyó marcadamente la infección invasiva por esta bacteria, sin embargo, aumentó la preocupación por las otras cepas tipificables y no tipificables (NTHi). La colonización previa con este patógeno puede convertirse en una fuente de infección invasiva. Este estudio tuvo como objetivo determinar la colonización por H. influenzae en 888 niños sanos menores de 24 meses de edad. La colonización fue 4,1% (37 muestras) mediante métodos moleculares (todas NTHi) y 1,1% (10 aislamientos) por cultivo (8/10 biotipo I y 2/10 biotipo IV). El antecedente de prematuridad se asoció con una mayor colonización en el análisis multivariado. De los aislamientos, 9/10 fueron resistentes a sulfametoxazol/trimetoprima, 3/10 a ampicilina y cefuroxima, 2/10 a azitromicina, y no se observó resistencia a ceftriaxona. Conocer el estado de portación de H. influenzae y los patrones locales de resistencia es de utilidad para la terapia antibiótica empírica en infecciones invasivas en las que se sospecha esta bacteria.
- 21 November 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (4) , 416-23
Open AccessDistribución de serotipos, biotipo y sensibilidad antibiótica de Haemophilus influenzae en niños portadores nasofaríngeos en Lima, Perú
Luego de la introducción de la vacuna Hib (Haemophilus influenzae tipo b) disminuyó marcadamente la infección invasiva por esta bacteria, sin embargo, aumentó la preocupación por las otras cepas tipificables y no tipificables (NTHi). La colonización previa con este patógeno puede convertirse en una fuente de infección invasiva. Este estudio tuvo como objetivo determinar la colonización por H. influenzae en 888 niños sanos menores de 24 meses de edad. La colonización fue 4,1% (37 muestras) mediante métodos moleculares (todas NTHi) y 1,1% (10 aislamientos) por cultivo (8/10 biotipo I y 2/10 biotipo IV). El antecedente de prematuridad se asoció con una mayor colonización en el análisis multivariado. De los aislamientos, 9/10 fueron resistentes a sulfametoxazol/trimetoprima, 3/10 a ampicilina y cefuroxima, 2/10 a azitromicina, y no se observó resistencia a ceftriaxona. Conocer el estado de portación de H. influenzae y los patrones locales de resistencia es de utilidad para la terapia antibiótica empírica en infecciones invasivas en las que se sospecha esta bacteria.
- Open Access
- 18 March 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (1) , 70-5
Detección de Streptococcus pneumoniae en líquidos estériles mediante una PCR en tiempo real (qPCR) en pacientes hospitalizados con sospecha de enfermedad neumocócica invasiva
The standard for diagnosing invasive pneumococcal disease (IPD) is to isolate pneumococcus in culture. However, the etiological agent cannot be identified in some patients, especially those who received empiricalantibiotic therapy. This study aimed to detect pneumococcus in normally sterile fluids by qPCR inpatients with suspected IPD hospitalized in Lima. qPCR had a detection limit of 1.2 x 101 genome copies/uL. Of the 71 clinical samples (51 were pleural fluid [PF] and 20 were cerebrospinal fluid [CSF]), 29.4% (28/71) were positive for pneumococcus by culture and 71.8% (51/71) were positive by qPCR, including 78.4% (40/51) in PF and 55.0% (11/20) in CSF. Of the positive samples, 13/51 were serotype 19A. The detection of pneumococcus was almost double by qPCR compared to the conventional microbiological method. Therefore, molecular methods such as qPCR should be implemented to improve the identification and timely treatment of IPD in Peru and in the region.
- 18 March 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (1) , 70-5
Open AccessDetección de Streptococcus pneumoniae en líquidos estériles mediante una PCR en tiempo real (qPCR) en pacientes hospitalizados con sospecha de enfermedad neumocócica invasiva
The standard for diagnosing invasive pneumococcal disease (IPD) is to isolate pneumococcus in culture. However, the etiological agent cannot be identified in some patients, especially those who received empiricalantibiotic therapy. This study aimed to detect pneumococcus in normally sterile fluids by qPCR inpatients with suspected IPD hospitalized in Lima. qPCR had a detection limit of 1.2 x 101 genome copies/uL. Of the 71 clinical samples (51 were pleural fluid [PF] and 20 were cerebrospinal fluid [CSF]), 29.4% (28/71) were positive for pneumococcus by culture and 71.8% (51/71) were positive by qPCR, including 78.4% (40/51) in PF and 55.0% (11/20) in CSF. Of the positive samples, 13/51 were serotype 19A. The detection of pneumococcus was almost double by qPCR compared to the conventional microbiological method. Therefore, molecular methods such as qPCR should be implemented to improve the identification and timely treatment of IPD in Peru and in the region.
- Open Access
- 12 March 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (1) , 63-9
Características clínicas y microbiológicas de pacientes pediátricos hospitalizados por neumonía neumocócica antes y después de la introducción de las vacunas conjugadas neumocócicas
The clinical and microbiological characteristics of pneumococcal pneumonia in children hospitalized in Lima were analyzed, before and after the introduction of pneumococcal conjugate vaccines (PCV). We reviewed cases that occurred between 2006-2019, in the pre-PCV7 (2006-2008), post-PCV7 (2009-2011) and post-PCV13 (2016-2019) periods. Of 128 patients with positive cultures (92 blood and 36 pleural fluid), most were infants in the pre-PCV7 (77.1%) and post-PCV7 (43.3%) studies, while in the post-PCV13 study they were mostly preschoolers (62%). We found an increase in complicated pneumonia cases from 14.6% to 72% and an increase in serotype 19A (6.3% to 68%). The most frequent sequence type was ST320 (31 isolates). Resistance to penicillin and ceftriaxone was low (6% and 2%, respectively), although higher in empyema (21.4% and 14.3%, respectively). Resistance to azithromycin increased from 27% to 92%. Penicillin remains the antibiotic of choice for the treatment of uncomplicated pneumococcal pneumonia in Lima.
- 12 March 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (1) , 63-9
Open AccessCaracterísticas clínicas y microbiológicas de pacientes pediátricos hospitalizados por neumonía neumocócica antes y después de la introducción de las vacunas conjugadas neumocócicas
The clinical and microbiological characteristics of pneumococcal pneumonia in children hospitalized in Lima were analyzed, before and after the introduction of pneumococcal conjugate vaccines (PCV). We reviewed cases that occurred between 2006-2019, in the pre-PCV7 (2006-2008), post-PCV7 (2009-2011) and post-PCV13 (2016-2019) periods. Of 128 patients with positive cultures (92 blood and 36 pleural fluid), most were infants in the pre-PCV7 (77.1%) and post-PCV7 (43.3%) studies, while in the post-PCV13 study they were mostly preschoolers (62%). We found an increase in complicated pneumonia cases from 14.6% to 72% and an increase in serotype 19A (6.3% to 68%). The most frequent sequence type was ST320 (31 isolates). Resistance to penicillin and ceftriaxone was low (6% and 2%, respectively), although higher in empyema (21.4% and 14.3%, respectively). Resistance to azithromycin increased from 27% to 92%. Penicillin remains the antibiotic of choice for the treatment of uncomplicated pneumococcal pneumonia in Lima.